This short video explores what patients think about the move to Amgevita. We spoke to a group of seven New Zealanders living with arthritis to find out how they feel about changing from the biological reference medicine, Humira, to the new biosimilar medicine, Amgevita.
Education
The hub for all your learning resources.
Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.